<Record>
<Term>Radioimmunoconjugate</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Radiopharmaceutical Compound</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioimmunoconjugate,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Immunoconjugate/Radioimmunoconjugate</ClassificationPath>
<BroaderTerm>Radioimmunoconjugate</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Radioimmunoconjugate,</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Immunoconjugate</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<ChildTerm>Iodine I 131 Monoclonal Antibody 8H9</ChildTerm>
<ChildTerm>Lutetium Lu-177-DOTA-Chimeric Monoclonal Antibody cG250</ChildTerm>
<ChildTerm>Bismuth Bi213 Monoclonal Antibody M195</ChildTerm>
<ChildTerm>Radiolabeled CC49</ChildTerm>
<ChildTerm>Yttrium 90-DOTA-Chimeric Monoclonal Antibody cG250</ChildTerm>
<ChildTerm>M A TAC Conjugated Pseudomonas EXO</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody BC8</ChildTerm>
<ChildTerm>Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12</ChildTerm>
<ChildTerm>Y 90 Monoclonal Antibody m170</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody Lym-1</ChildTerm>
<ChildTerm>Y 90 Monoclonal Antibody M195</ChildTerm>
<ChildTerm>Iodine I 131 Monoclonal Antibody CC49-deltaCH2</ChildTerm>
<ChildTerm>Lutetium Lu 177 Monoclonal Antibody CC49</ChildTerm>
<ChildTerm>Lutetium Lu 177 Monoclonal Antibody J591</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody B3</ChildTerm>
<ChildTerm>Arcitumomab</ChildTerm>
<ChildTerm>Tc 99m Monoclonal Antibody 170</ChildTerm>
<ChildTerm>Yttrium Y 90 Monoclonal Antibody B3</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody 3F8</ChildTerm>
<ChildTerm>In 111 Satumomab Pendetide</ChildTerm>
<ChildTerm>Iodine I 124 Chimeric Monoclonal Antibody G250</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody Anti-TAC</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody LL2</ChildTerm>
<ChildTerm>At 211 Monoclonal Antibody 81C6</ChildTerm>
<ChildTerm>Iodine I 131 Tositumomab</ChildTerm>
<ChildTerm>I131-COL1</ChildTerm>
<ChildTerm>Iodine-131 Human Serum Albumin</ChildTerm>
<ChildTerm>Yttrium 90 Monoclonal Antibody MN-14</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody F19</ChildTerm>
<ChildTerm>Technetium Tc 99m Epratuzumab</ChildTerm>
<ChildTerm>Y 90 Monoclonal Antibody CC49</ChildTerm>
<ChildTerm>Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12</ChildTerm>
<ChildTerm>Indium In 111 Monoclonal Antibody HuPAM4</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody A33</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody CC49</ChildTerm>
<ChildTerm>Gallium Ga 68 F(ab')2-Trastuzumab</ChildTerm>
<ChildTerm>Lutetium Lu 177-Capromab</ChildTerm>
<ChildTerm>Indium I 111 Bevacizumab</ChildTerm>
<ChildTerm>Y 90 Anti-CEA Monoclonal Antibody</ChildTerm>
<ChildTerm>Iodine I 125-Anti-EGFR-425 Monoclonal Antibody</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody BrE-3</ChildTerm>
<ChildTerm>Y 90 Monoclonal Antibody HMFG1</ChildTerm>
<ChildTerm>Yttrium Y90 (or Indium 111) labeled humanized monoclonal antibody BrE-3</ChildTerm>
<ChildTerm>Yttrium Y 90 Monoclonal Antibody Hu3S193</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody G-250</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody MN-14</ChildTerm>
<ChildTerm>I 131 Antiferritin Immunoglobulin</ChildTerm>
<ChildTerm>M A Idiotypic Determinants</ChildTerm>
<ChildTerm>Yttrium Y 90-Edotreotide</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody 81C6</ChildTerm>
<ChildTerm>I 123 Monoclonal Antibody 81C6</ChildTerm>
<ChildTerm>M A 131I Osteogenic Sarcoma</ChildTerm>
<ChildTerm>Yttrium 90 Humanized Epratuzumab</ChildTerm>
<ChildTerm>Yttrium Y 90 DOTA Monoclonal Antibody HuAFP31</ChildTerm>
<ChildTerm>Yttrium Y 90 DOTA Monoclonal Antibody HuPAM4</ChildTerm>
<ChildTerm>M A Radiolabeled Anti-Carcinoma</ChildTerm>
<ChildTerm>Indium In 111 CHX-A DTPA Trastuzumab</ChildTerm>
<ChildTerm>Iodine I 131 Monoclonal Antibody muJ591</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody Hu3S193</ChildTerm>
<ChildTerm>Indium 111 Chimeric Monoclonal Antibody 806</ChildTerm>
<ChildTerm>Y 90 Monoclonal Antibody Lym-1</ChildTerm>
<ChildTerm>Yttrium Y 90 Monoclonal Antibody BrE-3</ChildTerm>
<ChildTerm>Indium I 111 Chimeric Monoclonal Antibody G250</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody Lym-1</ChildTerm>
<ChildTerm>Copper Cu 64 Trastuzumab</ChildTerm>
<ChildTerm>In 111 CMD-193</ChildTerm>
<ChildTerm>M A Radiolabeled Anti-BRST Cancer</ChildTerm>
<ChildTerm>Yttrium Y 90 Daclizumab</ChildTerm>
<ChildTerm>Yttrium Y 90 Anti-CD66 Monoclonal Antibody BW250:183</ChildTerm>
<ChildTerm>I 124 Monoclonal Antibody A33</ChildTerm>
<ChildTerm>In 111 Ibritumomab Tiuxetan</ChildTerm>
<ChildTerm>In 111 Monoclonal Antibody M170</ChildTerm>
<ChildTerm>M A Radiolabeled T101 Human T-LYMP</ChildTerm>
<ChildTerm>Yttrium 90 Monoclonal Antibody T101</ChildTerm>
<ChildTerm>I 131 Monoclonal Antibody TNT-1:B</ChildTerm>
<Synonym>Radioimmunoconjugate</Synonym>
<Synonym>Radiolabeled Antibodies</Synonym>
<Description>Monoclonal antibodies (MoAb) conjugated with radioisotopes, i.e., I-131, Y-90, T-99, or In-111. Using radioimmunoconjugates in radiotherapy or radioimaging has the advantage of targeting cells carrying specific antigens, thereby limiting toxic effects on normal cells. Tumor eradication can be achieved by either the antibody-mediated immune response or by only the cytotoxic activity of the radiation.</Description>
<Source>NCI Thesaurus</Source>
</Record>
